BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29977016)

  • 1. Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism.
    Studd JB; Yang M; Li Z; Vijayakrishnan J; Lu Y; Yeoh AE; Paulsson K; Houlston RS
    Leukemia; 2019 Jan; 33(1):1-14. PubMed ID: 29977016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of CEBPE Gene Promoter Polymorphism (Rs2239630 G > A ) Assessment in Childhood B-cell Acute Lymphoblastic Leukemia.
    Aref S; El-Ghonemy M; Shimaa H; Darwish A; Abdelmabood S; Khaled N
    J Pediatr Hematol Oncol; 2023 Apr; 45(3):e334-e338. PubMed ID: 36897378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia.
    Han Y; Xue Y; Zhang J; Wu Y; Pan J; Wang Y; Shen J; Dai H; Bai S
    Cancer Genet Cytogenet; 2008 Dec; 187(2):125-9. PubMed ID: 19027493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional polymorphism in the CEBPE gene promoter influences acute lymphoblastic leukemia risk through interaction with the hematopoietic transcription factor Ikaros.
    Wiemels JL; de Smith AJ; Xiao J; Lee ST; Muench MO; Fomin ME; Zhou M; Hansen HM; Termuhlen A; Metayer C; Walsh KM
    Leukemia; 2016 May; 30(5):1194-7. PubMed ID: 26437776
    [No Abstract]   [Full Text] [Related]  

  • 5. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood.
    Prasad RB; Hosking FJ; Vijayakrishnan J; Papaemmanuil E; Koehler R; Greaves M; Sheridan E; Gast A; Kinsey SE; Lightfoot T; Roman E; Taylor M; Pritchard-Jones K; Stanulla M; Schrappe M; Bartram CR; Houlston RS; Kumar R; Hemminki K
    Blood; 2010 Mar; 115(9):1765-7. PubMed ID: 20042726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double CEBPE-IGH rearrangement due to chromosome duplication and cryptic insertion in an adult with B-cell acute lymphoblastic leukemia.
    Pierini V; Nofrini V; La Starza R; Barba G; Vitale A; Di Raimondo F; Matteucci C; Crescenzi B; Elia L; Gorello P; Storlazzi CT; Mecucci C
    Cancer Genet; 2011 Oct; 204(10):563-8. PubMed ID: 22137487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.
    Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEBPE polymorphism confers an increased risk of childhood acute lymphoblastic leukemia: a meta-analysis of 11 case-control studies with 5,639 cases and 10,036 controls.
    Wang C; Chen J; Sun H; Sun L; Liu Y
    Ann Hematol; 2015 Feb; 94(2):181-5. PubMed ID: 25195121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.
    Gharbi H; Ben Hassine I; Soltani I; Safra I; Ouerhani S; Bel Haj Othmen H; Teber M; Farah A; Amouri H; Toumi NH; Abdennebi S; Abbes S; Menif S
    Pediatr Hematol Oncol; 2016 Apr; 33(3):157-67. PubMed ID: 27184773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and molecular cytogenetic studies of a case of B-lineage acute lymphoblastic leukemia with t(14;14)(q11;q32)].
    Han YS; Xue YQ; Zhang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):137-40. PubMed ID: 22487819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.
    Papaemmanuil E; Hosking FJ; Vijayakrishnan J; Price A; Olver B; Sheridan E; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Tomlinson IP; Taylor M; Greaves M; Houlston RS
    Nat Genet; 2009 Sep; 41(9):1006-10. PubMed ID: 19684604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
    Duan H; Heckman CA; Boxer LM
    Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell precursor acute lymphoblastic leukemia with isolated t(14;19)(q32;q13) abnormality involving the CEBPG gene.
    Haghi N; Brody J; Mahmood N; Gheewala D; Allen SL; Sreekantaiah C; Zhang X
    Leuk Lymphoma; 2015; 56(10):2978-81. PubMed ID: 25669928
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population.
    Pastorczak A; Górniak P; Sherborne A; Hosking F; Trelińska J; Lejman M; Szczepański T; Borowiec M; Fendler W; Kowalczyk J; Houlston RS; Młynarski W
    Leuk Res; 2011 Nov; 35(11):1534-6. PubMed ID: 21889209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CEBPE rs2239633 genetic polymorphism on susceptibility to childhood acute lymphoblastic leukemia: an updated meta-analysis.
    Liu J; Weiling G; Xueqin L; Liang X; Linhong W; Zhongwen C
    Environ Health Prev Med; 2021 Jan; 26(1):2. PubMed ID: 33397280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia.
    Chapiro E; Russell L; Radford-Weiss I; Bastard C; Lessard M; Struski S; Cave H; Fert-Ferrer S; Barin C; Maarek O; Della-Valle V; Strefford JC; Berger R; Harrison CJ; Bernard OA; Nguyen-Khac F
    Blood; 2006 Nov; 108(10):3560-3. PubMed ID: 16873674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARID5B, CEBPE and PIP4K2A Germline Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia in Mexican Patients: A MIGICCL Study.
    Bekker-Méndez VC; Núñez-Enríquez JC; Torres Escalante JL; Alvarez-Olmos E; González-Montalvoc PM; Jiménez-Hernández E; Sansón AM; Leal YA; Ramos-Cervantes MT; Guerra-Castillo FX; Ortiz-Maganda MP; Flores-Lujano J; Pérez-Saldivar ML; Velazquez-Aviña MM; Bolea-Murga V; Torres-Nava JR; Amador-Sanchez R; Solis-Labastida KA; Rámirez-Bello J; Fragoso JM; Mejía-Aranguré JM;
    Arch Med Res; 2016 Nov; 47(8):623-628. PubMed ID: 28476190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of functional nucleotide and haplotype variants in the promoter of the CEBPE gene.
    Ryoo H; Kong M; Kim Y; Lee C
    J Hum Genet; 2013 Sep; 58(9):600-3. PubMed ID: 23719191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Genetic Variants in ARID5B, IKZF1 and CEBPE with Risk of Childhood de novo B-Lineage Acute Lymphoblastic Leukemia in India.
    Bhandari P; Ahmad F; Mandava S; Das BR
    Asian Pac J Cancer Prev; 2016; 17(8):3989-95. PubMed ID: 27644650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population.
    Wang Y; Chen J; Li J; Deng J; Rui Y; Lu Q; Wang M; Tong N; Zhang Z; Fang Y
    Gene; 2013 Jul; 524(2):203-7. PubMed ID: 23608171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.